Macy's, Inc.
For the period ended Aug 2, 2025. Filed Sep 10, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Aug 2, 2025 · Filed Sep 10, 2025
M$24.95+8.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| August 2, 2025 | February 1, 2025 | August 3, 2024 | |
|---|---|---|---|
| ASSETS | |||
| Current Assets: | |||
| Cash and cash equivalents | $829 | $1,306 | $646 |
| Receivables | 211 | 303 | 268 |
| Merchandise inventories | 4,342 | 4,468 | 4,378 |
| Prepaid expenses and other current assets | 430 | 385 | 403 |
| Income taxes receivable | 13 | 17 | 47 |
| Total Current Assets | 5,825 | 6,479 | 5,742 |
| Property and Equipment - net of accumulated depreciationand amortization of $4,396, $4,177 and $4,521 | 4,903 | 5,070 | 5,234 |
| Right of Use Assets | 2,210 | 2,243 | 2,345 |
| Goodwill | 828 | 828 | 828 |
| Other Intangible Assets – net | 423 | 425 | 428 |
| Other Assets | 1,362 | 1,357 | 1,291 |
| Total Assets | $15,551 | $16,402 | $15,868 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
| Current Liabilities: | |||
| Short-term debt | $194 | $6 | $6 |
| Merchandise accounts payable | 1,818 | 1,893 | 1,871 |
| Accounts payable and accrued liabilities | 2,195 | 2,625 | 2,127 |
| Income taxes payable | 12 | — | — |
| Total Current Liabilities | 4,219 | 4,524 | 4,004 |
| Long-Term Debt | 2,432 | 2,773 | 2,993 |
| Long-Term Lease Liabilities | 2,855 | 2,927 | 3,013 |
| Deferred Income Taxes | 723 | 724 | 725 |
| Other Liabilities | 871 | 902 | 932 |
| Shareholders' Equity | 4,451 | 4,552 | 4,201 |
| Total Liabilities and Shareholders’ Equity | $15,551 | $16,402 | $15,868 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.